Preclinical

For decades, the foundations of cancer treatment have been surgery, chemotherapy, and radiation therapy. However, these treatments are not always successful—hence, further research paved the way for immunotherapy, specifically, Chimeric Antigen Receptor (CAR) T-cell therapy. How CAR T-cell therapies work CAR T-cell therapy has been a huge area of research for over a decade, but...

Read more +

Recently, there have been published reports stating that a large proportion of studies published in high-impact scientific journals could not be...

Read more +

A sound preclinical plan coupled with expert oncology guidance can help identify biomarkers that can assist with patient selection—or help...

Read more +

Too often, new drugs fail during development due to poor study design and inadequate knowledge about the performance of a new drug. A large part of...

Read more +

If you’re exploring nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) or cancer-associated liver fibrosis, you may want...

Read more +

Ketogenic diets—which involve higher saturated fat, moderate protein and low carbohydrate consumption—have been successfully used to manage human...

Read more +

View More
Skip to content